RNAC
Cartesian Therapeutics, Inc.
Latest Form 4:Sale$24KbyMiljkovic Milos (Chief Medical Officer) · filed Jan 8, 2026
Cartesian Therapeutics, Inc. (RNAC) has 20 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Apr 6, 2026.
Insiders have net sold $259K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Carsten Brunn
- Employees:75
- HQ:Frederick, MD, US
- IPO:2016-06-22
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$259K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
Miljkovic MilosFirst filing | Chief Medical Officer | Sale | 3,573 | $24K | Jan 8 | SEC ↗ |
Brunn CarstenFirst filing | President and CEO | Sale | 23,766 | $162K | Jan 8 | SEC ↗ |
Davis BlaineFirst filing | Chief Financial Officer | Sale | 10,591 | $72K | Jan 8 | SEC ↗ |
Related companies
Cartesian Therapeutics, Inc. is in the Healthcare sector.